Skip to content

Mechanisms responsible for reduced erythropoiesis during androgen deprivation therapy in men with prostate cancer.

Study design not specified in the source record · Am J Physiol Endocrinol Metab · 2018. Source record refreshed; an explanation has not been reviewed.

Study design not specified in the source recordSource: PubMed · PMID 30325657

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Mechanisms responsible for reduced erythropoiesis during androgen deprivation therapy in men with prostate cancer.

Gagliano-Jucá T, Pencina KM, Ganz T et al.
Am J Physiol Endocrinol Metab · 2018

PubMed ID
30325657
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.